首页> 外国专利> Oxazetidinas Derivatives, pharmaceutical and Cosmetic compositions containing same and Use thereof for treating Dermatological Diseases fundamentally, and the respiratory, Digestive and cardiovascular, among others

Oxazetidinas Derivatives, pharmaceutical and Cosmetic compositions containing same and Use thereof for treating Dermatological Diseases fundamentally, and the respiratory, Digestive and cardiovascular, among others

机译:Oxazetidinas衍生物,含有该衍生物的药物和化妆品组合物及其在根本上治疗皮肤病以及呼吸道,消化道和心血管疾病的用途

摘要

This report covers the pharmaceutical field, especially in the treatment of hyperpigmentation and photosensitive skin diseases. More specifically, this refers to the less toxic promoter compound of m1r receptor, which is less toxic than other similar compounds. 1. Claim 1: consists of general formula (1),R1 represents a cyclopentyl methyl or 4-hydroxybutyl group; R2 represents a hydrogen atom or a methyl group; and salts and corresponding isomers of related general formula compounds.
机译:该报告涵盖制药领域,尤其是在色素沉着过度和光敏性皮肤病的治疗中。更具体地说,这是指m1r受体的毒性较小的启动子化合物,其毒性低于其他类似化合物。 1.权利要求1:由通式(1)组成,R1代表环戊基甲基或4-羟基丁基; R 2表示氢原子或甲基。以及相关通式化合物的盐和相应的异构体。

著录项

  • 公开/公告号AR086803A1

    专利类型

  • 公开/公告日2014-01-22

    原文格式PDF

  • 申请/专利权人 GALDERMA RESEARCH & DEVELOPMENT;

    申请/专利号AR2012P102343

  • 发明设计人 CLAIRE BOUIX-PETER;

    申请日2012-06-29

  • 分类号C07D403/12;A61K31/397;A61K31/4178;A61P3;A61P7;A61P11/02;A61P11/06;A61P13/12;A61P15/08;A61P15/10;A61P17;A61P17/04;A61P17/06;A61P17/10;A61P17/14;A61P19/02;A61P25/16;A61P25/28;A61P29;A61P35;A61P37;

  • 国家 AR

  • 入库时间 2022-08-21 15:58:52

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号